Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/9/16 → 11/30/24 |
Funding
- Biomedical Advanced Research and Development Authority: $126,576.38
Phase III, Randomized, Double-Blind, Placebo-Contolled, Parallel-Group, Study of AB103 as Comared to Placebo in Patients with Necrotizing Soft Tissue Infections (NSTI)
- Flynn, William (PI)
Project: Research